ICE Pharma's primary focus is on the production of active pharmaceutical ingredients, with Ursodeoxycholic Acid (UDCA) being the key component, utilized in the treatment of liver conditions and gallstones. The company specializes in creating a variety of bile acid derivatives that serve as excipients, nutraceutical ingredients, cell culture media, and intermediates. Additionally, ICE Pharma offers contract manufacturing services for both liquid and solid finished dosage forms, catering to branded and generic products. Advent International, a leading global private equity investor, has owned ICE Pharma since October 2019.
Products & Services
CDMO services for carbohydrates
CDMO services for finished dosage forms
Chenodeoxycholic Acid
Cholic Acid
Sites
ICE S.P.A. (BASALUZZO)
Audited
Country
ItalyCity
Area Produttiva
Address
Via Novi, 78, 15060 Area Produttiva AL, Italy
Raichem Medicare
Country
IndiaCity
Chicksugur
Ice Raichem Medicare
Country
ItalyCity
Reggio Emilia
Ice
Country
ItalyCity
Reggio Emilia
Address
Via Sicilia 8, 42122
ICE
Country
ItalyCity
Basaluzzo